Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA launches new priority review voucher program for select biopharmas
Sanofi
Biotech
Ventyx posts Parkinson's data ahead of potential Sanofi talks
The readout shows the effect of VTX3232 on biomarkers, providing data that will influence whether Sanofi takes up its right of first negotiation.
Nick Paul Taylor
Jun 17, 2025 9:05am
Sanofi vaccine vet vaults to GSK—Chutes & Ladders
Jun 13, 2025 8:30am
GSK snags longtime Sanofi exec to lead vaccine development
Jun 9, 2025 10:45am
Fierce Pharma
Sanofi buys Blueprint for $9.1B, its largest deal in 7 years
Jun 2, 2025 11:09am
Sanofi pays $15M for another STAT6 degrader from Nurix collab
Jun 2, 2025 9:50am
Sanofi's IL-33 drug fails COPD study
May 30, 2025 5:30am